The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects

Summary Objective Despite the frequent use of antiplatelet medication (AM) in the elderly patients, very few studies have investigated its prescription. We describe AM prescription through retrospective study in ambulatory elderly patients. Method All subjects aged over 80 years with a medical presc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical practice (Esher) 2017-12, Vol.71 (12), p.e13020-n/a
Hauptverfasser: Manckoundia, Patrick, Buzens, Jean‐Baptiste, Mahmoudi, Rachid, d'Athis, Philippe, Martin, Isabelle, Laborde, Caroline, Menu, Didier, Putot, Alain
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 12
container_start_page e13020
container_title International journal of clinical practice (Esher)
container_volume 71
creator Manckoundia, Patrick
Buzens, Jean‐Baptiste
Mahmoudi, Rachid
d'Athis, Philippe
Martin, Isabelle
Laborde, Caroline
Menu, Didier
Putot, Alain
description Summary Objective Despite the frequent use of antiplatelet medication (AM) in the elderly patients, very few studies have investigated its prescription. We describe AM prescription through retrospective study in ambulatory elderly patients. Method All subjects aged over 80 years with a medical prescription delivered in March 2015 and affiliated to the Mutualité Sociale Agricole de Bourgogne. Subjects with prescriptions for AM were compared with those without. Results A total of 15 141 ambulatory elderly patients (83‐89 years, 61.3% of women) were included and 4412 (29.14%) had a prescription for AM. The latter were more frequently men than those without AM (43% vs 36.93%, P 
doi_str_mv 10.1111/ijcp.13020
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01655895v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1942699627</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3140-fa21ea3d6506caa72c639cd1b3d87ee10cd9a51fc6b8479d2314e045e402e7263</originalsourceid><addsrcrecordid>eNp9kc9u1DAQhyMEoqVw4QGQj4CU4nFsJ-a2WvUfWgkO5Ww5zkT1yrsJdrJVTrxKn6VPhrNpe8QXezzffIf5ZdlHoOeQzje3tf05FJTRV9kplJzlwDi8Tu9CVrmgBZxk72LcUsqEqOjb7IRVilOh5Gn29_YOSR8w2uD6wXV70rXE7AfXezOgx4HssHHWHFtuTww5YJgI-gaDn0jf9aM_Nr-TVZqtI4bDsTaexGFspnkIxOMDcCBmV890lwRxrLdoh_g-e9MaH_HD032W_b68uF1f55ufVzfr1Sa3BXCat4YBmqKRgkprTMmsLJRtoC6aqkQEahtlBLRW1hUvVcPSFFIukFOGJZPFWfZl8d4Zr_vgdiZMujNOX682ev6jINNylDhAYj8vbB-6PyPGQe9ctOi92WM3Rg2KM6mUZGVCvy6oDV2MAdsXN1A9h6PncPQxnAR_evKOddrqC_qcRgJgAe6dx-k_Kn3zY_1rkf4Dh-qbFQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1942699627</pqid></control><display><type>article</type><title>The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects</title><source>Wiley Online Library - AutoHoldings Journals</source><creator>Manckoundia, Patrick ; Buzens, Jean‐Baptiste ; Mahmoudi, Rachid ; d'Athis, Philippe ; Martin, Isabelle ; Laborde, Caroline ; Menu, Didier ; Putot, Alain</creator><creatorcontrib>Manckoundia, Patrick ; Buzens, Jean‐Baptiste ; Mahmoudi, Rachid ; d'Athis, Philippe ; Martin, Isabelle ; Laborde, Caroline ; Menu, Didier ; Putot, Alain</creatorcontrib><description>Summary Objective Despite the frequent use of antiplatelet medication (AM) in the elderly patients, very few studies have investigated its prescription. We describe AM prescription through retrospective study in ambulatory elderly patients. Method All subjects aged over 80 years with a medical prescription delivered in March 2015 and affiliated to the Mutualité Sociale Agricole de Bourgogne. Subjects with prescriptions for AM were compared with those without. Results A total of 15 141 ambulatory elderly patients (83‐89 years, 61.3% of women) were included and 4412 (29.14%) had a prescription for AM. The latter were more frequently men than those without AM (43% vs 36.93%, P &lt; .0001) and more frequently had chronic comorbidities (77.24% vs 64.65%, P &lt; .0001). Compared with ambulatory subjects without AM, those with AM more frequently had coronary heart disease (35.15% vs 14.49%), severe hypertension (30% vs 25.65%), diabetes (27.42% vs 20.64%), peripheral arterial diseases (16.28% vs 5.96%) and disabling stroke (9% vs 5.56% (all P &lt; .0001). In addition, they had more prescriptions of beta‐blockers (45.24% vs 36.90%), angiotensin conversion enzyme inhibitor (31.35% vs 25.44%), calcium channel blockers (33.34% vs 27.90%), nitrate derivatives (10.6% vs 6.03%) or hypolipidemic agents (HA; 49.81% vs 29.72%) (all P &lt; .0001) than those without AM. Conclusion In this study, which is very interested for its size and the advanced age of the subjects, long‐course AM was prescribed in one third of ambulatory elderly patients. Coronary heart disease, severe hypertension and diabetes were more frequent in AM subjects. However, the low percentage of declared strokes was surprising. We provide additional data to doctors following subjects with AM.</description><identifier>ISSN: 1368-5031</identifier><identifier>EISSN: 1742-1241</identifier><identifier>DOI: 10.1111/ijcp.13020</identifier><identifier>PMID: 28940596</identifier><language>eng</language><publisher>England: Wiley</publisher><subject>Geriatry and gerontology ; Human health and pathology ; Life Sciences</subject><ispartof>International journal of clinical practice (Esher), 2017-12, Vol.71 (12), p.e13020-n/a</ispartof><rights>2017 John Wiley &amp; Sons Ltd</rights><rights>2017 John Wiley &amp; Sons Ltd.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3140-fa21ea3d6506caa72c639cd1b3d87ee10cd9a51fc6b8479d2314e045e402e7263</citedby><cites>FETCH-LOGICAL-c3140-fa21ea3d6506caa72c639cd1b3d87ee10cd9a51fc6b8479d2314e045e402e7263</cites><orcidid>0000-0002-4408-554X ; 0000-0002-5518-9803 ; 0000-0003-4741-1934</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijcp.13020$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijcp.13020$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28940596$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://u-bourgogne.hal.science/hal-01655895$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Manckoundia, Patrick</creatorcontrib><creatorcontrib>Buzens, Jean‐Baptiste</creatorcontrib><creatorcontrib>Mahmoudi, Rachid</creatorcontrib><creatorcontrib>d'Athis, Philippe</creatorcontrib><creatorcontrib>Martin, Isabelle</creatorcontrib><creatorcontrib>Laborde, Caroline</creatorcontrib><creatorcontrib>Menu, Didier</creatorcontrib><creatorcontrib>Putot, Alain</creatorcontrib><title>The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects</title><title>International journal of clinical practice (Esher)</title><addtitle>Int J Clin Pract</addtitle><description>Summary Objective Despite the frequent use of antiplatelet medication (AM) in the elderly patients, very few studies have investigated its prescription. We describe AM prescription through retrospective study in ambulatory elderly patients. Method All subjects aged over 80 years with a medical prescription delivered in March 2015 and affiliated to the Mutualité Sociale Agricole de Bourgogne. Subjects with prescriptions for AM were compared with those without. Results A total of 15 141 ambulatory elderly patients (83‐89 years, 61.3% of women) were included and 4412 (29.14%) had a prescription for AM. The latter were more frequently men than those without AM (43% vs 36.93%, P &lt; .0001) and more frequently had chronic comorbidities (77.24% vs 64.65%, P &lt; .0001). Compared with ambulatory subjects without AM, those with AM more frequently had coronary heart disease (35.15% vs 14.49%), severe hypertension (30% vs 25.65%), diabetes (27.42% vs 20.64%), peripheral arterial diseases (16.28% vs 5.96%) and disabling stroke (9% vs 5.56% (all P &lt; .0001). In addition, they had more prescriptions of beta‐blockers (45.24% vs 36.90%), angiotensin conversion enzyme inhibitor (31.35% vs 25.44%), calcium channel blockers (33.34% vs 27.90%), nitrate derivatives (10.6% vs 6.03%) or hypolipidemic agents (HA; 49.81% vs 29.72%) (all P &lt; .0001) than those without AM. Conclusion In this study, which is very interested for its size and the advanced age of the subjects, long‐course AM was prescribed in one third of ambulatory elderly patients. Coronary heart disease, severe hypertension and diabetes were more frequent in AM subjects. However, the low percentage of declared strokes was surprising. We provide additional data to doctors following subjects with AM.</description><subject>Geriatry and gerontology</subject><subject>Human health and pathology</subject><subject>Life Sciences</subject><issn>1368-5031</issn><issn>1742-1241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQhyMEoqVw4QGQj4CU4nFsJ-a2WvUfWgkO5Ww5zkT1yrsJdrJVTrxKn6VPhrNpe8QXezzffIf5ZdlHoOeQzje3tf05FJTRV9kplJzlwDi8Tu9CVrmgBZxk72LcUsqEqOjb7IRVilOh5Gn29_YOSR8w2uD6wXV70rXE7AfXezOgx4HssHHWHFtuTww5YJgI-gaDn0jf9aM_Nr-TVZqtI4bDsTaexGFspnkIxOMDcCBmV890lwRxrLdoh_g-e9MaH_HD032W_b68uF1f55ufVzfr1Sa3BXCat4YBmqKRgkprTMmsLJRtoC6aqkQEahtlBLRW1hUvVcPSFFIukFOGJZPFWfZl8d4Zr_vgdiZMujNOX682ev6jINNylDhAYj8vbB-6PyPGQe9ctOi92WM3Rg2KM6mUZGVCvy6oDV2MAdsXN1A9h6PncPQxnAR_evKOddrqC_qcRgJgAe6dx-k_Kn3zY_1rkf4Dh-qbFQ</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Manckoundia, Patrick</creator><creator>Buzens, Jean‐Baptiste</creator><creator>Mahmoudi, Rachid</creator><creator>d'Athis, Philippe</creator><creator>Martin, Isabelle</creator><creator>Laborde, Caroline</creator><creator>Menu, Didier</creator><creator>Putot, Alain</creator><general>Wiley</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-4408-554X</orcidid><orcidid>https://orcid.org/0000-0002-5518-9803</orcidid><orcidid>https://orcid.org/0000-0003-4741-1934</orcidid></search><sort><creationdate>201712</creationdate><title>The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects</title><author>Manckoundia, Patrick ; Buzens, Jean‐Baptiste ; Mahmoudi, Rachid ; d'Athis, Philippe ; Martin, Isabelle ; Laborde, Caroline ; Menu, Didier ; Putot, Alain</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3140-fa21ea3d6506caa72c639cd1b3d87ee10cd9a51fc6b8479d2314e045e402e7263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Geriatry and gerontology</topic><topic>Human health and pathology</topic><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manckoundia, Patrick</creatorcontrib><creatorcontrib>Buzens, Jean‐Baptiste</creatorcontrib><creatorcontrib>Mahmoudi, Rachid</creatorcontrib><creatorcontrib>d'Athis, Philippe</creatorcontrib><creatorcontrib>Martin, Isabelle</creatorcontrib><creatorcontrib>Laborde, Caroline</creatorcontrib><creatorcontrib>Menu, Didier</creatorcontrib><creatorcontrib>Putot, Alain</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>International journal of clinical practice (Esher)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manckoundia, Patrick</au><au>Buzens, Jean‐Baptiste</au><au>Mahmoudi, Rachid</au><au>d'Athis, Philippe</au><au>Martin, Isabelle</au><au>Laborde, Caroline</au><au>Menu, Didier</au><au>Putot, Alain</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects</atitle><jtitle>International journal of clinical practice (Esher)</jtitle><addtitle>Int J Clin Pract</addtitle><date>2017-12</date><risdate>2017</risdate><volume>71</volume><issue>12</issue><spage>e13020</spage><epage>n/a</epage><pages>e13020-n/a</pages><issn>1368-5031</issn><eissn>1742-1241</eissn><abstract>Summary Objective Despite the frequent use of antiplatelet medication (AM) in the elderly patients, very few studies have investigated its prescription. We describe AM prescription through retrospective study in ambulatory elderly patients. Method All subjects aged over 80 years with a medical prescription delivered in March 2015 and affiliated to the Mutualité Sociale Agricole de Bourgogne. Subjects with prescriptions for AM were compared with those without. Results A total of 15 141 ambulatory elderly patients (83‐89 years, 61.3% of women) were included and 4412 (29.14%) had a prescription for AM. The latter were more frequently men than those without AM (43% vs 36.93%, P &lt; .0001) and more frequently had chronic comorbidities (77.24% vs 64.65%, P &lt; .0001). Compared with ambulatory subjects without AM, those with AM more frequently had coronary heart disease (35.15% vs 14.49%), severe hypertension (30% vs 25.65%), diabetes (27.42% vs 20.64%), peripheral arterial diseases (16.28% vs 5.96%) and disabling stroke (9% vs 5.56% (all P &lt; .0001). In addition, they had more prescriptions of beta‐blockers (45.24% vs 36.90%), angiotensin conversion enzyme inhibitor (31.35% vs 25.44%), calcium channel blockers (33.34% vs 27.90%), nitrate derivatives (10.6% vs 6.03%) or hypolipidemic agents (HA; 49.81% vs 29.72%) (all P &lt; .0001) than those without AM. Conclusion In this study, which is very interested for its size and the advanced age of the subjects, long‐course AM was prescribed in one third of ambulatory elderly patients. Coronary heart disease, severe hypertension and diabetes were more frequent in AM subjects. However, the low percentage of declared strokes was surprising. We provide additional data to doctors following subjects with AM.</abstract><cop>England</cop><pub>Wiley</pub><pmid>28940596</pmid><doi>10.1111/ijcp.13020</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-4408-554X</orcidid><orcidid>https://orcid.org/0000-0002-5518-9803</orcidid><orcidid>https://orcid.org/0000-0003-4741-1934</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1368-5031
ispartof International journal of clinical practice (Esher), 2017-12, Vol.71 (12), p.e13020-n/a
issn 1368-5031
1742-1241
language eng
recordid cdi_hal_primary_oai_HAL_hal_01655895v1
source Wiley Online Library - AutoHoldings Journals
subjects Geriatry and gerontology
Human health and pathology
Life Sciences
title The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T06%3A37%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prescription%20of%20antiplatelet%20medication%20in%20a%20very%20elderly%20population:%20An%20observational%20study%20in%2015%C2%A0141%20ambulatory%20subjects&rft.jtitle=International%20journal%20of%20clinical%20practice%20(Esher)&rft.au=Manckoundia,%20Patrick&rft.date=2017-12&rft.volume=71&rft.issue=12&rft.spage=e13020&rft.epage=n/a&rft.pages=e13020-n/a&rft.issn=1368-5031&rft.eissn=1742-1241&rft_id=info:doi/10.1111/ijcp.13020&rft_dat=%3Cproquest_hal_p%3E1942699627%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1942699627&rft_id=info:pmid/28940596&rfr_iscdi=true